Nkarta(NKTX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

NKTX Nkarta

已收盘 04-28 16:00:00 EDT

2.77

-0.06

-2.12%

盘后2.76

-0.01-0.36%

17:53 EDT

最高2.90	最低2.75	成交量48.49万
今开2.82	昨收2.83	日振幅5.30%
总市值1.97亿	流通市值1.45亿	总股本7,103万
成交额135.59万	换手率0.92%	流通股本5,251万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"NKTX","market":"US","secType":"STK","nameCN":"Nkarta","latestPrice":2.77,"timestamp":1777406400000,"preClose":2.83,"halted":0,"volume":484866,"hourTrading":{"tag":"盘后","latestPrice":2.76,"preClose":2.77,"latestTime":"17:53 EDT","volume":799,"amount":2222.71,"timestamp":1777413184270,"change":-0.01,"changeRate":-0.00361,"amplitude":0.021661},"delay":0,"changeRate":-0.021201413427561856,"floatShares":52510907,"shares":71029512,"eps":-1.41,"marketStatus":"已收盘","change":-0.06,"latestTime":"04-28 16:00:00 EDT","open":2.82,"high":2.9,"low":2.75,"amount":1355872.2288,"amplitude":0.053004,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.41,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1777449600000},"marketStatusCode":5,"adr":0,"listingDate":1594353600000,"exchange":"NASDAQ","adjPreClose":2.83,"preHourTrading":{"tag":"盘前","latestPrice":2.82,"preClose":2.83,"latestTime":"09:25 EDT","volume":372,"amount":1051.5394680000002,"timestamp":1777382700028,"change":-0.01,"changeRate":-0.003534,"amplitude":0.028269},"postHourTrading":{"tag":"盘后","latestPrice":2.76,"preClose":2.77,"latestTime":"17:53 EDT","volume":799,"amount":2222.71,"timestamp":1777413184270,"change":-0.01,"changeRate":-0.00361,"amplitude":0.021661},"volumeRatio":0.400384,"impliedVol":0.7595,"impliedVolPercentile":0.6056},"requestUrl":"/m/hq/s/NKTX/wiki","defaultTab":"wiki","newsList":[{"id":"1113488077","title":"Nkarta与FDA就自身免疫疾病疗法Nkx019门诊给药方案达成一致，拓宽社区风湿病中心应用渠道","url":"https://stock-news.laohu8.com/highlight/detail?id=1113488077","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1113488077?lang=zh_cn&edition=full","pubTime":"2026-04-16 04:02","pubTimestamp":1776283334,"startTime":"0","endTime":"0","summary":"Nkarta公司宣布已与美国食品药品监督管理局（FDA）就Nkx019用于治疗自身免疫疾病的门诊给药方案达成协议。这一关键进展将显著提升该疗法的可及性，使其得以更广泛地应用于社区风湿病中心，为更多患者提供便利。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NKTX","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618960671","title":"Nkarta, Inc.盘中异动 早盘股价大涨5.20%报2.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2618960671","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618960671?lang=zh_cn&edition=full","pubTime":"2026-03-09 21:48","pubTimestamp":1773064134,"startTime":"0","endTime":"0","summary":"北京时间2026年03月09日21时48分，Nkarta, Inc.股票出现波动，股价大幅拉升5.20%。截至发稿，该股报2.63美元/股，成交量10.4136万股，换手率0.15%，振幅7.20%。Nkarta, Inc.股票所在的生物技术行业中，整体涨幅为0.22%。Nkarta, Inc.公司简介：Nkarta Inc 是一家临床阶段的生物制药公司，率先开发同种异体、现成的工程自然杀伤  细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309214854a45bd9dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309214854a45bd9dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NKTX","BK4139","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605407578","title":"Nkarta, Inc.盘中异动 临近午盘股价大涨5.42%报2.53美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2605407578","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605407578?lang=zh_cn&edition=full","pubTime":"2026-01-24 00:30","pubTimestamp":1769185807,"startTime":"0","endTime":"0","summary":"北京时间2026年01月24日00时30分，Nkarta, Inc.股票出现异动，股价快速拉升5.42%。截至发稿，该股报2.53美元/股，成交量53.5829万股，换手率0.75%，振幅4.58%。Nkarta, Inc.股票所在的生物技术行业中，整体跌幅为0.45%。Nkarta, Inc.公司简介：Nkarta Inc 是一家临床阶段的生物制药公司，率先开发同种异体、现成的工程自然杀伤  细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260124003007a44f2077&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260124003007a44f2077&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","NKTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154387407","title":"Nkarta第三季度每股收益为-0.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1154387407","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1154387407?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:19","pubTimestamp":1763572742,"startTime":"0","endTime":"0","summary":"11月10日，Nkarta第三季度净收入为-2171.5万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NKTX","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517519301","title":"Nkarta, Inc.盘中异动 股价大涨5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517519301","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517519301?lang=zh_cn&edition=full","pubTime":"2025-03-07 01:35","pubTimestamp":1741282534,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日01时35分，Nkarta, Inc.股票出现异动，股价急速拉升5.18%。Nkarta, Inc.股票所在的生物技术行业中，整体跌幅为0.81%。其相关个股中，Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com涨幅较大，Aeon Biopharma, Inc.、Plus Therapeutics, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为3868.21%、3112.13%、227.09%，振幅较大的相关个股有Surrozen Inc C/Wts 01/08/2031 、Plus Therapeutics, Inc.、Tonix Pharmaceuticals Holding Corp.，振幅分别为125.28%、122.63%、71.44%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307013534989ed55a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307013534989ed55a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NKTX","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516652558","title":"Nkarta, Inc.盘中异动 下午盘急速下跌5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516652558","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516652558?lang=zh_cn&edition=full","pubTime":"2025-03-04 02:35","pubTimestamp":1741026913,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日02时35分，Nkarta, Inc.股票出现波动，股价快速下跌5.14%。Nkarta, Inc.股票所在的生物技术行业中，整体涨幅为0.55%。其相关个股中，Bioxcel Therapeutics, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Radiopharm Theranostics Limited涨幅较大，Bioxcel Therapeutics, Inc.、Allarity Therapeutics, Inc.、Entero Therapeutics Inc.较为活跃，换手率分别为4399.43%、193.96%、179.64%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Entero Therapeutics Inc.，振幅分别为206.20%、119.50%、70.53%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304023513abe67965&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304023513abe67965&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","NKTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514773861","title":"Nkarta, Inc.盘中异动 下午盘股价大跌5.32%报1.78美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514773861","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514773861?lang=zh_cn&edition=full","pubTime":"2025-02-27 03:36","pubTimestamp":1740598573,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日03时36分，Nkarta, Inc.股票出现波动，股价快速下挫5.32%。截至发稿，该股报1.78美元/股，成交量77.056万股，换手率1.09%，振幅5.85%。Nkarta, Inc.股票所在的生物技术行业中，整体跌幅为0.44%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227033615a2553aa9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227033615a2553aa9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NKTX","BK4505","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514048218","title":"Nkarta, Inc.盘中异动 急速跳水5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514048218","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514048218?lang=zh_cn&edition=full","pubTime":"2025-02-26 02:59","pubTimestamp":1740509974,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日02时59分，Nkarta, Inc.股票出现异动，股价快速下挫5.08%。Nkarta, Inc.股票所在的生物技术行业中，整体涨幅为0.09%。其相关个股中，Organovo Holdings, Inc.、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Silexion Therapeutics Corp涨幅较大，Organovo Holdings, Inc.、Gt Biopharma, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为1938.26%、1152.07%、994.87%，振幅较大的相关个股有Organovo Holdings, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Silexion Therapeutics Corp，振幅分别为241.19%、112.90%、87.83%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226025934abdcbd08&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226025934abdcbd08&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NKTX","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513720691","title":"Nkarta, Inc.盘中异动 大幅跳水5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513720691","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513720691?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:03","pubTimestamp":1740409427,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时03分，Nkarta, Inc.股票出现波动，股价快速下挫5.12%。Nkarta, Inc.股票所在的生物技术行业中，整体涨幅为0.34%。其相关个股中，Pepgen Inc.、Avalo Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Pepgen Inc.、Aditxt, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为157.72%、70.42%、25.66%，振幅较大的相关个股有Pepgen Inc.、Telix Pharmaceutic、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 ，振幅分别为137.23%、55.69%、41.14%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230347962ea0ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230347962ea0ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NKTX","BK4139","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513196262","title":"Nkarta, Inc.盘中异动 下午盘股价大跌5.12%报2.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513196262","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513196262?lang=zh_cn&edition=full","pubTime":"2025-02-22 02:59","pubTimestamp":1740164374,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日02时59分，Nkarta, Inc.股票出现波动，股价大幅跳水5.12%。截至发稿，该股报2.04美元/股，成交量114.711万股，换手率1.63%，振幅6.98%。Nkarta, Inc.股票所在的生物技术行业中，整体涨幅为0.44%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222025934962bb52b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222025934962bb52b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","NKTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511913306","title":"Nkarta, Inc.盘中异动 早盘急速拉升5.19%报2.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511913306","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511913306?lang=zh_cn&edition=full","pubTime":"2025-02-14 22:43","pubTimestamp":1739544228,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日22时43分，Nkarta, Inc.股票出现波动，股价快速拉升5.19%。Nkarta, Inc.股票所在的生物技术行业中，整体涨幅为0.39%。其相关个股中，Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.涨幅较大，Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为1558.66%、445.99%、408.23%，振幅较大的相关个股有Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Klotho Neurosciences, Inc.，振幅分别为55.12%、32.93%、32.49%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021422434898858cc0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021422434898858cc0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","NKTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510533849","title":"Nkarta, Inc.盘中异动 早盘股价大跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510533849","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510533849?lang=zh_cn&edition=full","pubTime":"2025-02-11 23:05","pubTimestamp":1739286318,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日23时05分，Nkarta, Inc.股票出现波动，股价大幅下挫5.02%。Nkarta, Inc.股票所在的生物技术行业中，整体跌幅为1.41%。其相关个股中，Ocean Biomedical, Inc.、Dominari Holdings Inc.、Lipella Pharmaceuticals Inc.涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃，换手率分别为2492.40%、706.99%、319.90%，振幅较大的相关个股有Dominari Holdings Inc.、In8Bio, Inc.、Ocean Biomedical, Inc.，振幅分别为45.29%、37.99%、33.04%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502112305189881c3b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502112305189881c3b7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NKTX","BK4139","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510896461","title":"Nkarta, Inc.盘中异动 下午盘急速跳水5.07%报2.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510896461","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510896461?lang=zh_cn&edition=full","pubTime":"2025-02-11 02:11","pubTimestamp":1739211102,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日02时11分，Nkarta, Inc.股票出现波动，股价急速下跌5.07%。截至发稿，该股报2.06美元/股，成交量29.2112万股，换手率0.41%，振幅6.22%。Nkarta, Inc.股票所在的生物技术行业中，整体跌幅为0.18%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211021143961e2a13&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211021143961e2a13&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NKTX","BK4139","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509648723","title":"Nkarta, Inc.盘中异动 股价大跌5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509648723","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509648723?lang=zh_cn&edition=full","pubTime":"2025-02-07 23:55","pubTimestamp":1738943716,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日23时55分，Nkarta, Inc.股票出现异动，股价快速跳水5.13%。截至发稿，该股报2.22美元/股，成交量14.5168万股，换手率0.21%，振幅5.13%。Nkarta, Inc.股票所在的生物技术行业中，整体跌幅为0.42%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207235517961b47f3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207235517961b47f3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","NKTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509291287","title":"Nkarta, Inc.盘中异动 股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509291287","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509291287?lang=zh_cn&edition=full","pubTime":"2025-02-05 23:00","pubTimestamp":1738767636,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日23时00分，Nkarta, Inc.股票出现异动，股价快速拉升5.04%。截至发稿，该股报2.37美元/股，成交量6.291万股，换手率0.09%，振幅4.20%。Nkarta, Inc.股票所在的生物技术行业中，整体涨幅为1.73%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020523003696190e66&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020523003696190e66&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NKTX","BK4505","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508425521","title":"Nkarta, Inc.盘中异动 急速跳水5.56%报2.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508425521","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508425521?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:45","pubTimestamp":1738593903,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时45分，Nkarta, Inc.股票出现波动，股价快速下跌5.56%。截至发稿，该股报2.21美元/股，成交量6.7116万股，换手率0.10%，振幅3.85%。Nkarta, Inc.股票所在的生物技术行业中，整体跌幅为0.35%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020322450398797170&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020322450398797170&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NKTX","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507067413","title":"Nkarta, Inc.盘中异动 下午盘股价大涨5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507067413","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507067413?lang=zh_cn&edition=full","pubTime":"2025-01-31 03:01","pubTimestamp":1738263678,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日03时01分，Nkarta, Inc.股票出现异动，股价急速上涨5.13%。Nkarta, Inc.股票所在的生物技术行业中，整体涨幅为0.39%。其相关个股中，Tectonic Therapeutic, Inc.、Alterity Therapeutics Limited、Immatics N V C/Wts 01/07/2025 涨幅较大，Kazia Therapeutics Limited、Silexion Therapeutics Corp、Alterity Therapeutics Limited较为活跃，换手率分别为1780.54%、296.49%、238.13%，振幅较大的相关个股有Cero Therapeutics Holdings, Inc.、Immatics N V C/Wts 01/07/2025 、Alterity Therapeutics Limited，振幅分别为65.98%、63.82%、61.86%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131030118a23481a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131030118a23481a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NKTX","BK4505","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507465216","title":"Nkarta, Inc.盘中异动 大幅下挫5.53%报2.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507465216","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507465216?lang=zh_cn&edition=full","pubTime":"2025-01-30 03:16","pubTimestamp":1738178195,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日03时16分，Nkarta, Inc.股票出现波动，股价大幅下跌5.53%。截至发稿，该股报2.22美元/股，成交量38.9784万股，换手率0.55%，振幅4.68%。Nkarta, Inc.股票所在的生物技术行业中，整体涨幅为0.97%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130031635abbc8b42&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130031635abbc8b42&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NKTX","BK4139","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506517596","title":"Nkarta, Inc.盘中异动 早盘急速跳水5.37%报2.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506517596","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506517596?lang=zh_cn&edition=full","pubTime":"2025-01-28 23:09","pubTimestamp":1738076972,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日23时09分，Nkarta, Inc.股票出现波动，股价大幅跳水5.37%。截至发稿，该股报2.29美元/股，成交量15.7547万股，换手率0.22%，振幅5.37%。Nkarta, Inc.股票所在的生物技术行业中，整体跌幅为0.37%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128230932a232775a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128230932a232775a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NKTX","BK4505","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2504531917","title":"Nkarta, Inc.盘中异动 大幅拉升5.35%报2.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2504531917","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504531917?lang=zh_cn&edition=full","pubTime":"2025-01-17 00:23","pubTimestamp":1737044618,"startTime":"0","endTime":"0","summary":"北京时间2025年01月17日00时23分，Nkarta, Inc.股票出现波动，股价急速拉升5.35%。截至发稿，该股报2.36美元/股，成交量34.0963万股，换手率0.48%，振幅6.25%。Nkarta, Inc.股票所在的生物技术行业中，整体跌幅为0.42%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501170023389868a37f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501170023389868a37f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","NKTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.nkartatx.com","stockEarnings":[{"period":"1week","weight":-0.1891},{"period":"1month","weight":0.3738},{"period":"3month","weight":0.1142},{"period":"6month","weight":0.3541},{"period":"1year","weight":0.3412},{"period":"ytd","weight":0.5297}],"compareEarnings":[{"period":"1week","weight":0.0091},{"period":"1month","weight":0.1279},{"period":"3month","weight":0.0283},{"period":"6month","weight":0.0404},{"period":"1year","weight":0.2988},{"period":"ytd","weight":0.0488}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Nkarta, Inc.于2015年7月在特拉华州成立。该公司一家临床阶段的生物制药公司，致力于开发同种异体、现成的工程自然杀伤（“NK”）细胞疗法，用于治疗自身免疫性疾病或血液恶性肿瘤患者。该公司成立的信念是，工程NK细胞疗法可以通过提供具有临床意义、广泛可及且不受其他细胞治疗方法相关的安全问题影响的疗法来改变患者的生活。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.051655},{"month":2,"riseRate":0.5,"avgChangeRate":0.038672},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.082697},{"month":4,"riseRate":0.666667,"avgChangeRate":0.182365},{"month":5,"riseRate":0.2,"avgChangeRate":-0.136477},{"month":6,"riseRate":0.2,"avgChangeRate":-0.109268},{"month":7,"riseRate":1,"avgChangeRate":0.107935},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.06764},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.061634},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.060284},{"month":11,"riseRate":0.5,"avgChangeRate":-0.004483},{"month":12,"riseRate":0.333333,"avgChangeRate":0.310979}],"exchange":"NASDAQ","name":"Nkarta","nameEN":"Nkarta"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Nkarta(NKTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Nkarta(NKTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Nkarta,NKTX,Nkarta股票,Nkarta股票老虎,Nkarta股票老虎国际,Nkarta行情,Nkarta股票行情,Nkarta股价,Nkarta股市,Nkarta股票价格,Nkarta股票交易,Nkarta股票购买,Nkarta股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Nkarta(NKTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Nkarta(NKTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}